These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28042727)

  • 1. New evidence for cardiac benefit of postmenopausal hormone therapy.
    Mikkola TS; Savolainen-Peltonen H; Venetkoski M; Ylikorkala O
    Climacteric; 2017 Feb; 20(1):5-10. PubMed ID: 28042727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hot flushes and biochemical markers for cardiovascular disease: a randomized trial on hormone therapy.
    Tuomikoski P; Mikkola TS; Tikkanen MJ; Ylikorkala O
    Climacteric; 2010 Oct; 13(5):457-66. PubMed ID: 20443719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal hormone therapy and coronary heart disease in early postmenopausal women.
    Tuomikoski P; Mikkola TS
    Ann Med; 2014 Feb; 46(1):1-7. PubMed ID: 24266727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
    Tuomikoski P; Haapalahti P; Sarna S; Ylikorkala O; Mikkola TS
    Ann Med; 2010 Jul; 42(5):334-43. PubMed ID: 20429800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health characteristics of women beginning postmenopausal hormone therapy: have they changed since the publication of the Women's Health Initiative?
    Fournier A; Fritel X; Panjo H; Zins M; Ringa V
    Menopause; 2014 Jul; 21(7):687-93. PubMed ID: 24378763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral ultra-low dose continuous combined hormone replacement therapy with 0.5 mg 17β-oestradiol and 2.5 mg dydrogesterone for the treatment of vasomotor symptoms: results from a double-blind, controlled study.
    Stevenson JC; Durand G; Kahler E; Pertyński T
    Maturitas; 2010 Nov; 67(3):227-32. PubMed ID: 20688442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.
    Hodis HN; Mack WJ; Henderson VW; Shoupe D; Budoff MJ; Hwang-Levine J; Li Y; Feng M; Dustin L; Kono N; Stanczyk FZ; Selzer RH; Azen SP;
    N Engl J Med; 2016 Mar; 374(13):1221-31. PubMed ID: 27028912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen therapy for osteoporosis in the modern era.
    Levin VA; Jiang X; Kagan R
    Osteoporos Int; 2018 May; 29(5):1049-1055. PubMed ID: 29520604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone therapy: new questions and the case for new clinical trials.
    Manson JE; Bassuk SS; Harman SM; Brinton EA; Cedars MI; Lobo R; Merriam GR; Miller VM; Naftolin F; Santoro N
    Menopause; 2006; 13(1):139-47. PubMed ID: 16607110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrogen replacement in postmenopausal women.
    Sassarini J; Lumsden MA
    Age Ageing; 2015 Jul; 44(4):551-8. PubMed ID: 26070875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushes.
    Gerlinger C; Gude K; Schmelter T; Schaefers M; Endrikat J
    Climacteric; 2015; 18(4):512-7. PubMed ID: 26000627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and benefit considerations for menopausal hormone therapy.
    Pickar JH; Archer DF; Kagan R; Pinkerton JV; Taylor HS
    Expert Opin Drug Saf; 2017 Aug; 16(8):941-954. PubMed ID: 28664754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide after hormone therapy in postmenopausal women with chest pain and normal coronary angiogram.
    Kawano H; Nagayoshi Y; Soejima H; Tanaka Y; Hokamaki J; Miyamoto S; Miyazaki Y; Yamabe H; Ogawa H
    Menopause; 2008; 15(2):352-6. PubMed ID: 18090872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J; Graeser T; Mellinger U; Ertan K; Holz C
    Maturitas; 2007 Oct; 58(2):201-7. PubMed ID: 17889463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.